MDPI and ACS Style
van Veen, L.E.J.; van der Weijden, B.M.; Achten, N.B.; van der Lee, L.; Hol, J.; van Rossem, M.C.; Rijpert, M.; Oorthuys, A.O.J.; van Beek, R.H.T.; Dubbink-Verheij, G.H.;
et al. Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study. Antibiotics 2024, 13, 537.
https://doi.org/10.3390/antibiotics13060537
AMA Style
van Veen LEJ, van der Weijden BM, Achten NB, van der Lee L, Hol J, van Rossem MC, Rijpert M, Oorthuys AOJ, van Beek RHT, Dubbink-Verheij GH,
et al. Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study. Antibiotics. 2024; 13(6):537.
https://doi.org/10.3390/antibiotics13060537
Chicago/Turabian Style
van Veen, Liesanne E. J., Bo M. van der Weijden, Niek B. Achten, Lotte van der Lee, Jeroen Hol, Maaike C. van Rossem, Maarten Rijpert, Anna O. J. Oorthuys, Ron H. T. van Beek, Gerdien H. Dubbink-Verheij,
and et al. 2024. "Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study" Antibiotics 13, no. 6: 537.
https://doi.org/10.3390/antibiotics13060537